0086-400-080-9519
Global
Tissue Engineering and Regenerative Medicine Biomaterials Laboratory
CDMO Platform
Tissue Engineering and Regenerative Medicine Biomaterials Laboratory Decellularized Extracellular Matrix Pipeline Silk Fibroin Pipeline
The Healtech CDMO plantfrom undertakes the special project of "National 13th Five Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", realizing the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin protein", and further reserving various new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.

Healtech has established the core technology platform of decellularized extracellular matrix (AOBM) and silk fibroin (SFM), to provide the overall solution of tissue repair and organ reconstruction.Healtech provides technology upgrades and new project reservation services for manufacturing and sales enterprises, and now has established strategic cooperation relationship with many domestic and international pharmaceutical and medical device enterprises. Currently, The plantfrom has reserved more than 80 technical projects, applied for 37 national patents, obtained 12 national invention patent certificates, and 5 medical device registration certificates, continuously creating new value for the health industry.
Silk Fibroin
Platform

· The Silk Fibroin Platform has approximately 3,000 square meters of workshops with various purification levels that comply with GMP standards, including 100,000-class, 10,000-class, and localized 100-class workshops.
· The Silk Fibroin Platform has a complete range of equipment and facilities for research and development of silk fibroin technology.
· The Silk Fibroin Platform has low-temperature and low-humidity production lines for special product requirements of silk fibroin.
· The Silk Fibroin Platform is capable of supporting the research, development, and production of various biomaterial medical devices.
Technology Advantage
High Safety (Excellent Biocompatibility)

High Safety (Excellent Biocompatibility)

High purity natural protein

No risk of cross-contamination with humans

Degradation products can be normally absorbed by human body.

Silk fibroin sutures have been used clinically for 100 years.

Consult Now
High Effectiveness (with Biological Activity)

High Effectiveness (with Biological Activity)

High adhesion ability to cells

Be able to guide cell migration and tissue regeneration.

Consult Now
Biodegradable and Adjustable

Biodegradable and Adjustable

Biodegradable to peptides and amino acids

Degradation period can be regulated from 3 to 24 months.

Consult Now
Core Technology
Processing Technology of Silk Fibroin With Low Immunogenicity, High Molecular Weight and High Purity
Control Technology of Biodegradation Rate of Medical Silk Fibroin Materials
Physicochemical Modification Technology for Silk Fibroin Materials
Tissue-induced Silk Fibroin Material Molding Technology
Consult Now
Application
01

Cosmetic Medicine(Such as stamp-type microneedle injector,facial lines,injectable filler,sexual plastic surgery,post-medical dressings,etc.)

02

Traumatology Department(Such as wound dressing,diabetic foot,surgical sutures,etc.)

03

Cosmetic Products(Such as mask,milklotion,serum,conditioner,etc.)

04

Artificial Skin (Such as artificial skin, facial sculpture lines, etc.)

05

Artificial Organs (Such as artificial bone, blood vessels, cornea, meninges, etc.)

06

Sutures and Drug Carriers (Such as surgical sutures, antitumor drug carriers, drug capsules, etc.)

Consult Now

Online Consultation

Communicate with professionals online to quickly get the solutions you want

Follow Healtech

Telephone consultation

0086-400-080-9519 (9:00-18:00)